Literature DB >> 32475914

Association of Hypnotic Drug Use with Fall Incidents in Hospitalized Elderly Patients: A Case-Crossover Study.

Haruki Torii1, Motozumi Ando1, Hideaki Tomita2, Tomoko Kobaru1, Mahoko Tanaka1, Kazuhide Fujimoto1, Rumiko Shimizu1, Hiroaki Ikesue2, Satoshi Okusada2, Tohru Hashida2, Noriaki Kume1.   

Abstract

We investigated whether use of hypnotic drugs, including benzodiazepine receptor agonists, as well as ramelteon and suvorexant are associated with fall incidents in elderly inpatients aged no less than 75 years, who were hospitalized at an acute care general hospital in Japan, between November 1st, 2016 and October 31st, 2017. Multivariate analysis results were reported as odds ratio (OR) with 95% confidence interval (CI). Following to a case-crossover study protocol, the time windows of the case and the control days were assigned to the day or the days, which are one day or 2-8 d before the fall incidents, respectively. In the enrolled 111 patients, the accumulated total available numbers of the cases and the control days were 111 and 554 patient days, respectively. Hypnotic drug use was significantly associated with fall incidents (OR: 2.85, 95% CI: 1.03-7.90, p = 0.04). Especially benzodiazepine receptor agonists (OR: 5.79, 95% CI: 1.52-22.1, p = 0.01) showed statistically significant association with fall incidents. In contrast, neither ramelteon (OR: 7.95, 95% CI: 0.72-87.9, p = 0.09) nor suvorexant (OR: 0.25, 95% CI: 0.06-1.06, p = 0.06) were significantly associated with fall incidents. Thus, benzodiazepine receptor agonists, but not ramelteon or suvorexant, showed significant association with fall incidents. Therefore, special care should be taken especially when benzodiazepine receptor agonists are administrated to elderly subjects. In contrast, fall risk may be much less in patients treated with ramelteon or suvorexant. These results could help us to conduct safer drug treatment for insomnia patients aged no less than 75 years.

Entities:  

Keywords:  benzodiazepine receptor agonist; elderly patient; fall incident; hypnotic drug; ramelteon; suvorexant

Mesh:

Substances:

Year:  2020        PMID: 32475914     DOI: 10.1248/bpb.b19-00684

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

Review 1.  Adding Insult to Injury: Sleep Deficiency in Hospitalized Patients.

Authors:  Wissam Mansour; Melissa Knauert
Journal:  Clin Chest Med       Date:  2022-06       Impact factor: 4.967

2.  Treatment of Heart Failure Patients with Anxiolytics Is Associated with Adverse Outcomes, with and without Depression.

Authors:  Donna R Zwas; Andre Keren; Offer Amir; Israel Gotsman
Journal:  J Clin Med       Date:  2020-12-07       Impact factor: 4.241

3.  External validation of a new predictive model for falls among inpatients using the official Japanese ADL scale, Bedriddenness ranks: a double-centered prospective cohort study.

Authors:  Masaki Tago; Naoko E Katsuki; Eiji Nakatani; Midori Tokushima; Akiko Dogomori; Kazumi Mori; Shun Yamashita; Yoshimasa Oda; Shu-Ichi Yamashita
Journal:  BMC Geriatr       Date:  2022-04-15       Impact factor: 4.070

4.  Balance dysfunction the most significant cause of in-hospital falls in patients taking hypnotic drugs: A retrospective study.

Authors:  Ryuki Hashida; Hiroo Matsuse; Shinji Yokoyama; Sayuri Kawano; Eriko Higashi; Hiroshi Tajma; Masafumi Bekki; Sohei Iwanaga; Koji Hara; Yosuke Nakamura; Yuji Kaneyuki; Takeshi Nago; Yoshihiro Fukumoto; Motohiro Ozone; Naohisa Uchimura; Naoto Shiba
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

5.  Residual effects of low dose of suvorexant, zolpidem, and ramelteon in healthy elderly subjects: A randomized double-blind study.

Authors:  Sachiko Ito Uemura; Aya Imanishi; Yoshino Terui; Insung Park; Masahiro Satake; GoEun Han; Takanobu Shioya; Takashi Kanbayashi; Seiji Nishino
Journal:  Neuropsychopharmacol Rep       Date:  2022-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.